Amarin Corp Plcuk (AMRN) Current Taxes (2010)
Amarin Corp Plcuk (AMRN) reported Current Taxes of $585000.0 for Q4 2010.
Amarin Corp Plcuk (AMRN) Current Taxes (2010) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 1 years of Current Taxes data on file, last reported at $585000.0 in Q4 2010.
- Current Taxes for Q4 2010 came in at $585000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2010 was $585000.0 (changed N/A YoY), and the FY2010 annual result was $585000.0, changed N/A from the prior year.
- Current Taxes steadied at $585000.0 in Q4 2010 per AMRN's latest filing.
- Over five years, Current Taxes peaked at $585000.0 in Q4 2010 and troughed at $585000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -748.24 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 1.09 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 3.95 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | - |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 3.13 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Amarin Corp Plcuk | 6.77 Bn | 6.59 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 585,000.00 |